Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

NCT00595673 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

428

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: PB127 for injectable suspension

Sponsor

Point Biomedical